Crescent Capital Bdc Stock Alpha and Beta Analysis

CCAP Stock  USD 19.18  0.04  0.21%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Crescent Capital BDC. It also helps investors analyze the systematic and unsystematic risks associated with investing in Crescent Capital over a specified time horizon. Remember, high Crescent Capital's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Crescent Capital's market risk premium analysis include:
Beta
0.56
Alpha
0.0362
Risk
0.94
Sharpe Ratio
0.12
Expected Return
0.11
Please note that although Crescent Capital alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., Dow Jones Industrial index.) So in this particular case, Crescent Capital did 0.04  better than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of Crescent Capital BDC stock's relative risk over its benchmark. Crescent Capital BDC has a beta of 0.56  . As returns on the market increase, Crescent Capital's returns are expected to increase less than the market. However, during the bear market, the loss of holding Crescent Capital is expected to be smaller as well. At this time, Crescent Capital's Enterprise Value Over EBITDA is relatively stable compared to the past year. As of 11/26/2024, Enterprise Value Multiple is likely to grow to 21.69, while Price Book Value Ratio is likely to drop 0.80.

Enterprise Value

1.53 Billion

Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
  
Check out Crescent Capital Backtesting, Crescent Capital Valuation, Crescent Capital Correlation, Crescent Capital Hype Analysis, Crescent Capital Volatility, Crescent Capital History and analyze Crescent Capital Performance.

Crescent Capital Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Crescent Capital market risk premium is the additional return an investor will receive from holding Crescent Capital long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Crescent Capital. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Crescent Capital's performance over market.
α0.04   β0.56

Crescent Capital expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Crescent Capital's Buy-and-hold return. Our buy-and-hold chart shows how Crescent Capital performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

Crescent Capital Market Price Analysis

Market price analysis indicators help investors to evaluate how Crescent Capital stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Crescent Capital shares will generate the highest return on investment. By understating and applying Crescent Capital stock market price indicators, traders can identify Crescent Capital position entry and exit signals to maximize returns.

Crescent Capital Return and Market Media

The median price of Crescent Capital for the period between Wed, Aug 28, 2024 and Tue, Nov 26, 2024 is 18.3 with a coefficient of variation of 2.27. The daily time series for the period is distributed with a sample standard deviation of 0.42, arithmetic mean of 18.32, and mean deviation of 0.31. The Stock received substential amount of media coverage during this period.
 Price Growth (%)  
       Timeline  
1
Crescent Capital BDC, Inc. Receives Average Rating of Moderate Buy from Brokerages - MarketBeat
09/30/2024
2
Acquisition by Gerhard Lombard of 1500 shares of Crescent Capital at 18.275 subject to Rule 16b-3
10/25/2024
3
What To Expect From Crescent Capital BDC Inc Q3 2024 Earnings
11/11/2024
4
Crescent Capital BDC, Inc. Reports Third Quarter 2024 Earnings ResultsDeclares a Fourth Quarter Base Dividend of 0.42 Per Share, and a Third Quarter Supplementa...
11/12/2024
5
Crescent Capital BDC Inc Q3 2024 Earnings Call Highlights Strong Income and Dividend ...
11/13/2024
6
Crescent Capital BDC, Inc. Given Consensus Recommendation of Moderate Buy by Brokerages - MarketBeat
11/19/2024

About Crescent Capital Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Crescent or other stocks. Alpha measures the amount that position in Crescent Capital BDC has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
 2021 2022 2023 2024 (projected)
Dividend Yield0.09520.140.10.0521
Price To Sales Ratio6.1619.523.393.22

Crescent Capital Upcoming Company Events

As portrayed in its financial statements, the presentation of Crescent Capital's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Crescent Capital's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Crescent Capital's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Crescent Capital. Please utilize our Beneish M Score to check the likelihood of Crescent Capital's management manipulating its earnings.
21st of February 2024
Upcoming Quarterly Report
View
8th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
21st of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Build Portfolio with Crescent Capital

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations

Additional Tools for Crescent Stock Analysis

When running Crescent Capital's price analysis, check to measure Crescent Capital's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Crescent Capital is operating at the current time. Most of Crescent Capital's value examination focuses on studying past and present price action to predict the probability of Crescent Capital's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Crescent Capital's price. Additionally, you may evaluate how the addition of Crescent Capital to your portfolios can decrease your overall portfolio volatility.